Literature DB >> 7714773

Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide.

S S Greenberg1, J Xie, J M Zatarain, D R Kapusta, M J Miller.   

Abstract

The cobalt atom of hydroxocobalamin (OHC) binds cyanide and nitric oxide (NO) and OHC attenuates vascular responses to NO in vitro. NO mediates the hypotension of endotoxemia. Thus, we tested the postulate that OHC may attenuate the acute phase hypotension and toxicity associated with administration of Escherichia coli endotoxin (LPS). Rats were given OHC (20 mg/kg i.v.) or phosphate-buffered saline (PBS, 1 ml/kg i.v.) 30 min before or 15 min after giving LPS (0.8 mg/kg i.v.). Administration of OHC to PBS-treated control rats did not affect mean arterial pressure (MAP), heart rate or the plasma or urine content of the reactive nitrogen intermediates nitrate and nitrite (RNI). LPS decreased MAP by 50 mm Hg in PBS-treated rats and increased the plasma and urinary content of RNI. Administration of OHC to PBS-treated rats did not affect MAP or RNI. However, treatment with OHC before or after giving LPS attenuated LPS-induced hypotension and increases in plasma RNI and enhanced LPS-induced urinary excretion of RNI. OHC (20 mg/kg i.p.) or cyanocobalamin (10 mg/kg i.p.) given to Swiss-Webster mice 30 min before giving LPS (16 mg/kg i.p.) decreased the 24-hr mortality of LPS from 80 to 50% and the 36- and 96-hr mortality from 100 to 60% (OHC) or 70% (cyanocobalamin). Urine obtained from conscious rats given LPS (5 mg/kg i.p.) and OHC (20 mg/kg i.p.) exhibited a UV-visible absorbance spectrum with absorbance peaks characteristic of that formed after coincubation of NO and OHC.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7714773

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  The reaction of HOCl and cyanocobalamin: corrin destruction and the liberation of cyanogen chloride.

Authors:  Husam M Abu-Soud; Dhiman Maitra; Jaeman Byun; Carlos Eduardo A Souza; Jashoman Banerjee; Ghassan M Saed; Michael P Diamond; Peter R Andreana; Subramaniam Pennathur
Journal:  Free Radic Biol Med       Date:  2011-11-10       Impact factor: 7.376

2.  Redetermination of the X-ray structure of nitroxylcobalamin: base-on nitroxylcobalamin exhibits a remarkably long Co-N(dimethylbenzimidazole) bond distance.

Authors:  Hanaa A Hassanin; Mohamed F El-Shahat; Serena DeBeer; Clyde A Smith; Nicola E Brasch
Journal:  Dalton Trans       Date:  2010-10-04       Impact factor: 4.390

3.  Inhibition of nitric oxide synthase by cobalamins and cobinamides.

Authors:  J Brice Weinberg; Youwei Chen; Ning Jiang; Bethany E Beasley; John C Salerno; Dipak K Ghosh
Journal:  Free Radic Biol Med       Date:  2009-03-27       Impact factor: 7.376

4.  Vitamin B12 protects against superoxide-induced cell injury in human aortic endothelial cells.

Authors:  Edward S Moreira; Nicola E Brasch; June Yun
Journal:  Free Radic Biol Med       Date:  2011-06-02       Impact factor: 7.376

5.  Mechanistic Studies on the Reaction of Nitrocobalamin with Glutathione: Kinetic evidence for formation of an aquacobalamin intermediate.

Authors:  David T Walker; Rohan S Dassanayake; Kamille A Garcia; Riya Mukherjee; Nicola E Brasch
Journal:  Eur J Inorg Chem       Date:  2013-06-01       Impact factor: 2.524

6.  Failure of L-NAME to cause inhibition of nitric oxide synthesis: role of inducible nitric oxide synthase.

Authors:  M J Miller; J H Thompson; X Liu; S Eloby-Childress; H Sadowska-Krowicka; X J Zhang; D A Clark
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

Review 7.  The complex role of iNOS in acutely rejecting cardiac transplants.

Authors:  Galen M Pieper; Allan M Roza
Journal:  Free Radic Biol Med       Date:  2008-02-07       Impact factor: 7.376

8.  Pulse radiolysis studies on the reaction of the reduced vitamin B₁₂ complex Cob(II)alamin with superoxide.

Authors:  Rohan S Dassanayake; Diane E Cabelli; Nicola E Brasch
Journal:  Chembiochem       Date:  2013-05-13       Impact factor: 3.164

9.  Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin.

Authors:  Joseph A Bauer; Bei H Morrison; Ronald W Grane; Barbara S Jacobs; Sally Dabney; Ana M Gamero; Kevin A Carnevale; Daniel J Smith; Judith Drazba; Bellur Seetharam; Daniel J Lindner
Journal:  J Natl Cancer Inst       Date:  2002-07-03       Impact factor: 13.506

10.  NMR spectroscopy and molecular modelling studies of nitrosylcobalamin: further evidence that the deprotonated, base-off form is important for nitrosylcobalamin in solution.

Authors:  Hanaa A Hassanin; Luciana Hannibal; Donald W Jacobsen; Kenneth L Brown; Helder M Marques; Nicola E Brasch
Journal:  Dalton Trans       Date:  2008-12-05       Impact factor: 4.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.